Froedtert Hospital
Milwaukee, Wisconsin, 53226, United States
NCT Number: NCT06645132
The purpose of this study is to pilot test the feasibility of providing patients diagnosed with a hematologic malignancy, undergoing an allogeneic bone marrow transplant, a wearable device and smartphone app (similar to a Fitbit), that would send personalized reminders to move during their post-transplant inpatient hospital stay to promote physical recovery and well-being.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Not applicable
Milwaukee, Wisconsin, 53226, United States
Enrolled patients who have been diagnosed with a hematologic malignancy and are scheduled to undergo an allogeneic bone marrow transplant will use a custom-designed wearable device and smartphone application as a behavioral intervention to cue exercise. Participants will be asked to wear the wearable device for the duration of their post-transplant inpatient hospital stay.
Aim 1. To examine the potential efficacy of the wearable device + smartphone application to prompt alloBMT patients to move.
Aim 2. To receive participant feedback on their experience participating in the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exercise intervention leveraging wearable devices and a custom smartphone application to cue exercise as a reminder during idle time during an inpatient hospital stay, post allogenic bone marrow transplant.
Time frame: cumulative percent from day 1 through discharge from hospital, on average day 30
Efficacy will be evaluated by examining the percentage of time participants responded to the cued exercise prompts.
Time frame: day 10
Patient experience will be evaluated by looking at the central tendencies of the ratings from the post-participation evaluation survey.
Medical College of Wisconsin
Other
Pilot Study to Understand the Feasibility of Implementing a Wearable Device Cueing System Following Bone Marrow Transplant
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05873205
Blood Cancer, Hematologic Diseases
Basking Ridge, New Jersey, United States
View Trial DetailsNCT06904066
Blood Cancer, Blood Protein Disorders
Bethesda, Maryland, United States
View Trial DetailsNCT07714044
Blood Cancer, Blood Cancers
Piscataway, New Jersey, United States
View Trial DetailsNCT06469307
Blood Cancer, Hematologic Diseases
Boston, Massachusetts, United States
View Trial Details